Hints and tips:
...GSK had been planning to spin off the unit, in which it holds a 68 per cent stake, but has been under pressure to consider a sale, including from US hedge fund Elliott Management....
...Activist investors including US hedge fund Elliott Management have put pressure on Walmsley to explore other options — including a sale — if it can generate greater returns for shareholders....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Samuel Johar, who chairs board advisory group Buchanan Harvey, said the purchase underlined the Anglo-Swedish company’s transformation from “prey to predator”, six-and-a-half years after Pfizer swooped on...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The immunology specialist has not attracted any suitors until now, even though frustrated investors, such as activist firm Elliott, have long hoped for a takeover....
...Among the victors are: Alexion’s chief executive Ludwig Hantson, who stands to make $56m from a golden parachute clause if he leaves following the deal’s completion, according to FT calculations; Elliott...
...London and Washington told the FT that Donald Trump vented in “apoplectic” fury at Boris Johnson over Britain’s decision to allow China’s Huawei a role in its 5G mobile networks, and activist hedge fund Elliott...
...Jeffrey Kindler, former chairman and CEO of Pfizer, has joined Blackstone as a senior adviser. EQT Partners named Olof Svensson as its new head of shareholder relations....
...Other high-profile failures include Kraft Heinz’s $143bn bid to buy Anglo-Dutch consumer group Unilever, Monsanto’s multiple attempts to acquire Swiss agribusiness rival Syngenta and Pfizer’s effort to buy...
...(NYT) Scandal taints Japan Inc Japan’s elite manufacturers — Kobe Steel, Mitsubishi Materials and Subaru, among others — were thought to be models of elite efficiency....
...China Inc remains mesmerised by Trump's fiery economic nationalism and frets about the threat of a trade war; but the go-slow on takeover activity is driven mainly by Beijing’s clampdown on capital outflows...
...Pfizer’s $160bn takeover of Allergan was due to be finalised in the second half of this year....
...Pfizer shares fell 2.7 per cent to $31.33 while shares in Allergan fell 3.6 per cent to $301.70....
...Asset managers are preparing for the arrival of Ucits V in March, which will introduce new rules on asset managers’ pay....
...It agreed to be acquired by Dell after persistent demands by hedge fund Elliott Management that it break itself up....
...“Everyone I speak to in the market agrees with Elliott, but none of them are going to come out against Samsung,” says one local asset manager....
...The chutzpah of controlling shareholder Elliott Advisors is admirable. Long-termists should still steer clear. jonathan.guthrie@ft.com BSRC: kate.burgess@ft.com...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...tells 900 staff of redundancy risk - RBS brings some cheer with improved ‘core’ profits - National Express and Elliott close to ‘peace deal’ - Central banks are now stockpiling gold bullion...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Novell rose 28 per cent to $6.08 after the software company received an unsolicited $2bn buy-out offer from hedge fund Elliott Associates. Elliott currently holds about 8.5 per cent of the stock....
International Edition